Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles E Mahan

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Thrombosis Research|July 31, 2012
Regulatory, policy and quality update for venous thromboembolism and stroke in United States hospitalsCharles E Mahan
Neurocritical Care|June 24, 2020
Reply to "Key Points to Consider When Evaluating Andexxa for Formulary Addition"Charles E Mahan
Journal of Thrombosis and Thrombolysis|May 9, 2013
A 1-year drug utilization evaluation of protamine in hospitalized patients to identify possible future roles of heparin and low molecular weight heparin reversal agentsCharles E Mahan
Journal of Thrombosis and Thrombolysis|January 22, 2015
Practical aspects of treatment with target specific anticoagulants: initiation, payment and current market, transitions, and venous thromboembolism treatmentCharles E Mahan
The American Journal of Managed Care|January 4, 2018
Venous thromboembolism: role of pharmacists and managed care considerationsTuesdy Horner, Charles E Mahan
Pharmacotherapy|November 6, 2012
Performance of new anticoagulants for thromboprophylaxis in patients undergoing hip and knee replacement surgeryCharles E Mahan, Scott Kaatz
Stroke|June 28, 2014
Stroke prevention in patients with atrial fibrillation and renal dysfunctionScott Kaatz, Charles E Mahan
Thrombosis Research|May 3, 2011
New antithrombotics: the impact on global health careCharles E Mahan, John Fanikos
Hospital Practice (1995)|May 18, 2010
Venous thromboembolism prevention: a systematic review of methods to improve prophylaxis and decrease events in the hospitalized patientCharles E Mahan, Alexander C Spyropoulos
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 8, 2013
ASHP therapeutic position statement on the role of pharmacotherapy in preventing venous thromboembolism in hospitalized patientsCharles E Mahan, Alex C Spyropoulos
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Thrombosis Research|July 31, 2012
Regulatory, policy and quality update for venous thromboembolism and stroke in United States hospitalsCharles E Mahan
Neurocritical Care|June 24, 2020
Reply to "Key Points to Consider When Evaluating Andexxa for Formulary Addition"Charles E Mahan
Journal of Thrombosis and Thrombolysis|May 9, 2013
A 1-year drug utilization evaluation of protamine in hospitalized patients to identify possible future roles of heparin and low molecular weight heparin reversal agentsCharles E Mahan
Journal of Thrombosis and Thrombolysis|January 22, 2015
Practical aspects of treatment with target specific anticoagulants: initiation, payment and current market, transitions, and venous thromboembolism treatmentCharles E Mahan
The American Journal of Managed Care|January 4, 2018
Venous thromboembolism: role of pharmacists and managed care considerationsTuesdy Horner, Charles E Mahan
Pharmacotherapy|November 6, 2012
Performance of new anticoagulants for thromboprophylaxis in patients undergoing hip and knee replacement surgeryCharles E Mahan, Scott Kaatz
Stroke|June 28, 2014
Stroke prevention in patients with atrial fibrillation and renal dysfunctionScott Kaatz, Charles E Mahan
Thrombosis Research|May 3, 2011
New antithrombotics: the impact on global health careCharles E Mahan, John Fanikos
Hospital Practice (1995)|May 18, 2010
Venous thromboembolism prevention: a systematic review of methods to improve prophylaxis and decrease events in the hospitalized patientCharles E Mahan, Alexander C Spyropoulos
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 8, 2013
ASHP therapeutic position statement on the role of pharmacotherapy in preventing venous thromboembolism in hospitalized patientsCharles E Mahan, Alex C Spyropoulos
Pageof 4